CORDIS · 101118739 · HORIZON
AxoBrain Mapping the axolotl brain and its regeneration
Coordinator: INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH (AT)
The Axolotl is an extraordinary model system to study regeneration in tetrapods. Remarkably, the axolotl isable to regenerate parts of the brain after major injury, however the molecular mechanisms that orchestrateregeneration are unclear, and the completeness of functional circuit and behavioral recovery is unknown. Ourvision is to develop the axolotl model system to rigorously study central nervous system regeneration, anduse discoveries from the axolotl to design novel strategies for regenerating mammalian tissues. The mappingof brain cell types and connections in the axolotl will also hav…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
EU contribution: €8.9M awarded to the consortium. The project runs over approximately 6 years from 2024-04-01 to 2030-03-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from AT
see all →- EMPOWER — Eco-operated, Modular, highly efficient, and flexible multi-POWERtrain for long-haul heavy-duty vehicles101096028 · HORIZON · €18.0M
- M-ERA.NET3 — ERA-NET for research and innovation on materials and battery technologies, supporting the European Green Deal.958174 · H2020 · €15.0M
- iPC — individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology826121 · H2020 · €14.7M
- MORE-TEM — MOmentum and position REsolved mapping Transmission Electron energy loss Microscope951215 · H2020 · €14.0M
- PoCCardio — Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio)101095432 · HORIZON · €14.0M
- ThoriumNuclearClock — Thorium nuclear clocks for fundamental tests of physics856415 · H2020 · €13.8M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-ERC-SYG funding scheme.
- What is the EU contribution?
- The European Commission contributes €8.9M toward a total project budget of €8.9M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call ERC-2023-SyG.
- Who coordinates the project?
- The project is coordinated by INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH (AT).
- What is the project timeline?
- The project runs from 2024-04-01 to 2030-03-31 — approximately 6 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101118739.